6491 - 6500 of 8808 Results
Title
Year
-
OPENTitle: Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s modelsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 607End Page: 620Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1873-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6123262Citation Count: 132
- Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease2019OPENTitle: Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 74Issue #:Start Page: 76End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7374981Citation Count: 14
-
RESTRICTEDTitle: MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease PatientsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 3Start Page: 2092End Page: 2100Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1219-1Citation Count: 21
-
OPENTitle: Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 120Issue #:Start Page: 76End Page: 87Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.003Best OA location URL: https://doi.org/10.1016/j.nbd.2018.09.003Citation Count: 18
-
OPENTitle: Evaluating community health workers' attributes, roles, and pathways of action in immigrant communitiesJournal Name: Preventive MedicinePublisher: Elsevier BVVol: 103Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ypmed.2017.07.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6354577Citation Count: 41
-
OPENTitle: Incorporating spatial constraint in co-activation pattern analysis to explore the dynamics of resting-state networks: An application to Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 172Issue #:Start Page: 64End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.01.019Citation Count: 35
-
OPENTitle: Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasisJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.2020105531Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8762563Citation Count: 23
-
OPENTitle: Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 62Issue #:Start Page: 172End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.019Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996113002659Citation Count: 78
-
OPENTitle: Neuropsychological Test Performances and Depression in Early-Stage De Novo Parkinson’s DiseaseJournal Name: Archives of Clinical NeuropsychologyPublisher: Oxford University Press (OUP)Vol: 36Issue #: 1Start Page: 112End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/arclin/acz067Best OA location URL: https://academic.oup.com/acn/article-pdf/36/1/112/35858436/acz067.pdfCitation Count: 5
-
RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016Citation Count: 0